Terms: = Prostate cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Treatment
5 results:
1. Carboplatin in Metastatic Castrate Resistant prostate cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT).
Pemberton L; Allen C; Handel E; Weickhardt A; Shapiro J; Tran B; Taylor RA; Risbridger GP; Pook DW
Clin Genitourin Cancer; 2024 Apr; 22(2):580-585. PubMed ID: 38402090
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic syndrome-related prognostic index: Predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer.
Ren C; Wang Q; Wang S; Zhou H; Xu M; Li H; Li Y; Chen X; Liu X
Front Endocrinol (Lausanne); 2023; 14():1148117. PubMed ID: 37033267
[TBL] [Abstract] [Full Text] [Related]
3. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort.
Palm A; Theorell-Haglöw J; Isakson J; Ljunggren M; Sundh J; Ekström MP; Grote L
BMJ Open; 2023 Mar; 13(3):e064501. PubMed ID: 36868588
[TBL] [Abstract] [Full Text] [Related]
4. Stereotactic Body Radiotherapy for Oligometastatic prostate cancer Recurrence: A Meta-analysis.
Viani GA; Arruda CV; Hamamura AC; Faustino AC; Freitas Bendo Danelichen A; Guimarães FS
Am J Clin Oncol; 2020 Feb; 43(2):73-81. PubMed ID: 31809327
[TBL] [Abstract] [Full Text] [Related]
5. prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy.
Iremashvili V; Pelaez L; Jordá M; Manoharan M; Rosenberg DL; Soloway MS
Urology; 2012 Nov; 80(5):1063-9. PubMed ID: 23107397
[TBL] [Abstract] [Full Text] [Related]
